摘要
目的:探索研究射干麻黄汤加减治疗小儿哮喘的临床疗效及安全性。方法:选取小儿哮喘患者总共120例,随机分成观察组和对照组,每组各60例。观察组与对照组的患儿均给予常规治疗,在此基础上给予观察组患儿加用射干麻黄汤加减方汤剂。结果:观察组总有效率为98.33%,对照组总有效率为85.0%,观察组的总有效率高于对照组,差异具有统计学意义(P<0.05)。且观察组患儿的不良反应发生率远低于对照组,差异具有统计学意义(P<0.05)。结论:射干麻黄汤加减治疗小儿哮喘具有很好的临床效果,且不良反应少,安全性高,值得临床推广运用。
Objective:To explore security and efficacy of the Shegan Mahuang decoction on pediatric asthma. Methods:60 cases were randomly divided into the observed group and the control group, 30 cases for each. The control group was given the conventional treatment. The observed group was given the Shegan Mahuang decoction more. Results: The total efficiency in the observed group was 98.33%, better than that in the control group (85.0%). The incidence of adverse reactions in the observed group was lower than that in the control group. The difference was statistically significant (P<0.05). Conclusion:The Shegan Mahuang decoction was effective on pediatric asthma, with less adverse reactions, higher security, and was worthy of promotion.
出处
《中医临床研究》
2015年第14期68-69,共2页
Clinical Journal Of Chinese Medicine
关键词
射干麻黄汤
小儿哮喘
不良反应
The Shegan Mahuang decoction
Pediatric asthma
Adverse reactions
